The global healthcare industry is witnessing a transformative shift in cancer treatment methodologies, with the Alpha Emitters Market emerging as one of the most promising segments within nuclear medicine and radiopharmaceutical innovation. According to industry research, the market is experiencing strong expansion driven by increasing adoption of targeted alpha therapy (TAT), rising cancer...